Developing and Validating a Bundle for Safe Intra-Hospital Transporting of the Critically Ill Patients: Mixed Qualitative Design With Delphi Approach.

The aim of this study was to develop a bundle to increase safety of intra-hospital transport in critically ill patients. A qualitative design with Delphi approach was conducted for creation of an intra-hospital transport bundle in 3 steps. First, doctors and nurses were questioned about their encounters with intra-hospital transport incidents.

Soluble CD163 impact as a prognostic biomarker in chronic lymphocytic leukemia.

Chronic lymphocytic leukemia (CLL) is a malignant blood disorder in which there is an excess of white blood cells (lymphocytes) in blood and lymphoid tissues. CLL patients experience different clinical behaviors with diversity in disease course and outcome. Accordingly, prognostic markers are crucial for employing appropriate therapy protocols.

CD24 Gene Expression as a Risk Factor for Non-Alcoholic Fatty Liver Disease.

Unlabelled: In light of increasing NAFLD prevalence, early detection and diagnosis are needed for decision-making in clinical practice and could be helpful in the management of patients with NAFLD. The goal of this study was to evaluate the diagnostic accuracy of CD24 gene expression as a non-invasive tool to detect hepatic steatosis for diagnosis of NAFLD at early stage. These findings will aid in the creation of a viable diagnostic approach.

Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease.

Background And Aims: NAFLD is one of the fast-growing health problems that affects up to 25% of people worldwide. Numerous miRNAs have been clarified as important regulators of liver pathophysiology, including NAFLD. Thus, we investigated the expression of the MiRNA-34a and MiRNA-192 as diagnostic markers for NAFLD.

Evaluation of cell-mediated immunity of E.coli nanovaccines in chickens.

Nanovaccine is a revolutionary type of immunizations for various diseases that is simple to manufacture and administer. As a result, we are working to develop innovative nanovaccines against E. coli, which is capable of causing disease both inside and outside of its predilection sites, causing respiratory and systemic disease (colibacillosis).

Performance of serum CD163 as a marker of fibrosis in patients with NAFLD.

Background And Aims: CD163, a surface hemoglobin-haptoglobin scavenger receptor, is expressed on macrophages and monocytes and up-regulated during macrophage activation. This study aimed to evaluate CD163 in nonalcoholic steatohepatitis patients as a diagnostic and prognostic marker in such patients.

Methods: Serum samples were collected from 41 NAFLD patients and 14 healthy controls.

Potential improvement of the immune response of chickens against E. coli vaccine by using two forms of chitosan nanoparticles.

Colibacillosis disease has an important economic impact on poultry production worldwide. It is one of the most common causes of mortality in commercial layer and breeder chickens. Avian pathogenic Escherichia coli (APEC) is the main cause of this disease.

Critical care nurses' perception of barriers and supportive behaviors in end-of-life care.

Aim: To investigate critical care nurses' perceptions of barriers and supportive behaviors in providing end of life (EOL) care to dying patients and their families.

Methods: The study involved a convenient sample of 70 nurses who were involved in caring for critically ill patients. Data were collected using a structured interview sheet.